CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Generics  /  Abhijit Zutshi

Abhijit Zutshi

Chief Commercial Officer

Abhijit Zutshi

Abhijit Zutshi

Chief Commercial Officer

Mr. Abhijit Zutshi is Chief Commercial Officer of Biocon Limited with overall responsibility for its Generics business Commercial operations.

In his over two decades at Biocon, Abhijit has had successful stints in diverse roles across marketing, sales, business development and portfolio selection for both small molecules and biologics.

Prior to assuming his current role, Abhijit served as the Commercial Head of Global Generics Formulations and was instrumental in leading and growing the Formulations business across geographies since its inception.

He was instrumental in setting up the commercial infrastructure in the U.S. for Biocon’s formulation business in the USA and was involved in the successful launch of the Company’s first generic formulation in the country in 2017.

Abhijit had also previously headed Biocon’s North American operations where he was responsible for B2B sales, marketing, and business development of the Company’s entire portfolio of bulk drugs and biosimilars.

Before joining Biocon, Abhijit worked with Pfizer as a product specialist for their specialty products division.

He has a bachelor’s degree in Pharmaceutical Science with a major in Pharmacology and a Diploma in Business Management. He also attended Harvard Business School’s Program for Leadership Development program.

Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>